Cargando…

Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting

BACKGROUND: Data capture is one of the most expensive phases during the conduct of a clinical trial and the increasing use of electronic health records (EHR) offers significant savings to clinical research. To facilitate these secondary uses of routinely collected patient data, it is beneficial to k...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruland, Philipp, McGilchrist, Mark, Zapletal, Eric, Acosta, Dionisio, Proeve, Johann, Askin, Scott, Ganslandt, Thomas, Doods, Justin, Dugas, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118882/
https://www.ncbi.nlm.nih.gov/pubmed/27875988
http://dx.doi.org/10.1186/s12874-016-0259-3
_version_ 1782469011413401600
author Bruland, Philipp
McGilchrist, Mark
Zapletal, Eric
Acosta, Dionisio
Proeve, Johann
Askin, Scott
Ganslandt, Thomas
Doods, Justin
Dugas, Martin
author_facet Bruland, Philipp
McGilchrist, Mark
Zapletal, Eric
Acosta, Dionisio
Proeve, Johann
Askin, Scott
Ganslandt, Thomas
Doods, Justin
Dugas, Martin
author_sort Bruland, Philipp
collection PubMed
description BACKGROUND: Data capture is one of the most expensive phases during the conduct of a clinical trial and the increasing use of electronic health records (EHR) offers significant savings to clinical research. To facilitate these secondary uses of routinely collected patient data, it is beneficial to know what data elements are captured in clinical trials. Therefore our aim here is to determine the most commonly used data elements in clinical trials and their availability in hospital EHR systems. METHODS: Case report forms for 23 clinical trials in differing disease areas were analyzed. Through an iterative and consensus-based process of medical informatics professionals from academia and trial experts from the European pharmaceutical industry, data elements were compiled for all disease areas and with special focus on the reporting of adverse events. Afterwards, data elements were identified and statistics acquired from hospital sites providing data to the EHR4CR project. RESULTS: The analysis identified 133 unique data elements. Fifty elements were congruent with a published data inventory for patient recruitment and 83 new elements were identified for clinical trial execution, including adverse event reporting. Demographic and laboratory elements lead the list of available elements in hospitals EHR systems. For the reporting of serious adverse events only very few elements could be identified in the patient records. CONCLUSIONS: Common data elements in clinical trials have been identified and their availability in hospital systems elucidated. Several elements, often those related to reimbursement, are frequently available whereas more specialized elements are ranked at the bottom of the data inventory list. Hospitals that want to obtain the benefits of reusing data for research from their EHR are now able to prioritize their efforts based on this common data element list. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12874-016-0259-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5118882
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51188822016-11-28 Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting Bruland, Philipp McGilchrist, Mark Zapletal, Eric Acosta, Dionisio Proeve, Johann Askin, Scott Ganslandt, Thomas Doods, Justin Dugas, Martin BMC Med Res Methodol Research Article BACKGROUND: Data capture is one of the most expensive phases during the conduct of a clinical trial and the increasing use of electronic health records (EHR) offers significant savings to clinical research. To facilitate these secondary uses of routinely collected patient data, it is beneficial to know what data elements are captured in clinical trials. Therefore our aim here is to determine the most commonly used data elements in clinical trials and their availability in hospital EHR systems. METHODS: Case report forms for 23 clinical trials in differing disease areas were analyzed. Through an iterative and consensus-based process of medical informatics professionals from academia and trial experts from the European pharmaceutical industry, data elements were compiled for all disease areas and with special focus on the reporting of adverse events. Afterwards, data elements were identified and statistics acquired from hospital sites providing data to the EHR4CR project. RESULTS: The analysis identified 133 unique data elements. Fifty elements were congruent with a published data inventory for patient recruitment and 83 new elements were identified for clinical trial execution, including adverse event reporting. Demographic and laboratory elements lead the list of available elements in hospitals EHR systems. For the reporting of serious adverse events only very few elements could be identified in the patient records. CONCLUSIONS: Common data elements in clinical trials have been identified and their availability in hospital systems elucidated. Several elements, often those related to reimbursement, are frequently available whereas more specialized elements are ranked at the bottom of the data inventory list. Hospitals that want to obtain the benefits of reusing data for research from their EHR are now able to prioritize their efforts based on this common data element list. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12874-016-0259-3) contains supplementary material, which is available to authorized users. BioMed Central 2016-11-22 /pmc/articles/PMC5118882/ /pubmed/27875988 http://dx.doi.org/10.1186/s12874-016-0259-3 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Bruland, Philipp
McGilchrist, Mark
Zapletal, Eric
Acosta, Dionisio
Proeve, Johann
Askin, Scott
Ganslandt, Thomas
Doods, Justin
Dugas, Martin
Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting
title Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting
title_full Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting
title_fullStr Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting
title_full_unstemmed Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting
title_short Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting
title_sort common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118882/
https://www.ncbi.nlm.nih.gov/pubmed/27875988
http://dx.doi.org/10.1186/s12874-016-0259-3
work_keys_str_mv AT brulandphilipp commondataelementsforsecondaryuseofelectronichealthrecorddataforclinicaltrialexecutionandseriousadverseeventreporting
AT mcgilchristmark commondataelementsforsecondaryuseofelectronichealthrecorddataforclinicaltrialexecutionandseriousadverseeventreporting
AT zapletaleric commondataelementsforsecondaryuseofelectronichealthrecorddataforclinicaltrialexecutionandseriousadverseeventreporting
AT acostadionisio commondataelementsforsecondaryuseofelectronichealthrecorddataforclinicaltrialexecutionandseriousadverseeventreporting
AT proevejohann commondataelementsforsecondaryuseofelectronichealthrecorddataforclinicaltrialexecutionandseriousadverseeventreporting
AT askinscott commondataelementsforsecondaryuseofelectronichealthrecorddataforclinicaltrialexecutionandseriousadverseeventreporting
AT ganslandtthomas commondataelementsforsecondaryuseofelectronichealthrecorddataforclinicaltrialexecutionandseriousadverseeventreporting
AT doodsjustin commondataelementsforsecondaryuseofelectronichealthrecorddataforclinicaltrialexecutionandseriousadverseeventreporting
AT dugasmartin commondataelementsforsecondaryuseofelectronichealthrecorddataforclinicaltrialexecutionandseriousadverseeventreporting